Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFA-281 in Painful Lumbosacral Radiculopathy
NCT06649747Phase 2Not yet recruiting
- Sponsor
- AfaSci, Inc.
- Start
- Apr 2027
- Primary completion
- Mar 2032
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of AFA-281 in lumbosacral radiculopathy, sponsored by AfaSci, Inc.. Planned start Apr 2027; status: not yet recruiting.
02
Drugs
AFA-281
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NCT06649747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06649747.